These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22057179)

  • 41. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
    Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melatonin treatment reduces the severity of experimental Trypanosoma cruzi infection.
    Santello FH; Frare EO; dos Santos CD; Toldo MP; Kawasse LM; Zucoloto S; do Prado JC
    J Pineal Res; 2007 Apr; 42(4):359-63. PubMed ID: 17439552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.
    Campos MA; Gazzinelli RT
    Mediators Inflamm; 2004 Jun; 13(3):139-43. PubMed ID: 15223603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Update on the treatment of Chagas' disease].
    Apt W; Zulantay I
    Rev Med Chil; 2011 Feb; 139(2):247-57. PubMed ID: 21773664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paradoxical effects of vitamin C in Chagas disease.
    Castanheira JRPT; Castanho REP; Rocha H; Pagliari C; Duarte MIS; Therezo ALS; Chagas EFB; Martins LPA
    Parasitol Int; 2018 Oct; 67(5):547-555. PubMed ID: 29733902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia.
    Tatakihara VL; Malvezi AD; Panis C; Cecchini R; Zanluqui NG; Yamauchi LM; Martins MI; da Silva RV; Yamada-Ogatta SF; Rizzo LV; Martins-Pinge MC; Pinge-Filho P
    Chem Biol Interact; 2015 Feb; 227():104-11. PubMed ID: 25559858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis.
    Mendonça AAS; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Talvani A; Natali AJ; Novaes RD
    Life Sci; 2019 Aug; 230():141-149. PubMed ID: 31129142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease.
    Pedra-Rezende Y; Barbosa JMC; Bombaça ACS; Dantas-Pereira L; Gibaldi D; Vilar-Pereira G; Dos Santos HAM; Ramos IP; Silva-Gomes NL; Moreira OC; Lannes-Vieira J; Menna-Barreto RFS
    Front Immunol; 2021; 12():712034. PubMed ID: 34804007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Oxidative Stress and Chronic Inflammatory Process in Chagas Disease: Role of Exosomes and Contributing Genetic Factors.
    Maldonado E; Rojas DA; Urbina F; Solari A
    Oxid Med Cell Longev; 2021; 2021():4993452. PubMed ID: 34976301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunomodulatory properties and anti-apoptotic effects of zinc and melatonin in an experimental model of chronic Chagas disease.
    Brazão V; Filipin Mdel V; Santello FH; Azevedo AP; Toldo MP; de Morais FR; do Prado JC
    Immunobiology; 2015 May; 220(5):626-33. PubMed ID: 25604665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of vitamin C supplementation on acute phase Chagas disease in experimentally infected mice with Trypanosoma cruzi QM1 strain.
    Marim RG; Gusmão AS; Castanho RE; Deminice R; Therezo AL; Jordão Júnior AA; Martins LP
    Rev Inst Med Trop Sao Paulo; 2012 Dec; 54(6):319-23. PubMed ID: 23152316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.
    Waghabi MC; de Souza EM; de Oliveira GM; Keramidas M; Feige JJ; Araújo-Jorge TC; Bailly S
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4694-701. PubMed ID: 19738024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T. cruzi infection among aged rats: Melatonin as a promising therapeutic molecule.
    Brazão V; Santello FH; Colato RP; do Prado JC
    Exp Gerontol; 2020 Jul; 135():110922. PubMed ID: 32151734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective role of ETA endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats.
    Camargos ER; Rocha LL; Rachid MA; Almeida AP; Ferreira AJ; Teixeira AL; Chiari E; Barton M; Teixeira MM; Machado CR
    Microbes Infect; 2004 Jun; 6(7):650-6. PubMed ID: 15158772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melatonin: Antioxidant and modulatory properties in age-related changes during Trypanosoma cruzi infection.
    Brazão V; Santello FH; Colato RP; Mazotti TT; Tazinafo LF; Toldo MPA; do Vale GT; Tirapelli CR; do Prado JC
    J Pineal Res; 2017 Aug; 63(1):. PubMed ID: 28370218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1,3,4-Thiadiazole derivatives of R-(+)-limonene benzaldehyde-thiosemicarbazones cause death in Trypanosoma cruzi through oxidative stress.
    Martins SC; Lazarin-Bidóia D; Desoti VC; Falzirolli H; da Silva CC; Ueda-Nakamura T; Silva SO; Nakamura CV
    Microbes Infect; 2016 Dec; 18(12):787-797. PubMed ID: 27484335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.
    Molina-Berríos A; Campos-Estrada C; Henriquez N; Faúndez M; Torres G; Castillo C; Escanilla S; Kemmerling U; Morello A; López-Muñoz RA; Maya JD
    PLoS Negl Trop Dis; 2013; 7(4):e2173. PubMed ID: 23638194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular therapy in Chagas' disease: potential applications in patients with chronic cardiomyopathy.
    Soares MB; Garcia S; Campos de Carvalho AC; Ribeiro dos Santos R
    Regen Med; 2007 May; 2(3):257-64. PubMed ID: 17511562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.